Ellis Investment Partners’s Colgate-Palmolive CL Stock Holding History

Ellis Investment Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,496	Closed	-$227K	–	237
2024 Q4	$227K	Buy	2,496 +3	+0.1%	+$286	0.04%	218
2024 Q3	$259K	Buy	2,493 +2	+0.1%	+$204	0.05%	205
2024 Q2	$242K	Buy	2,491 +18	+0.7%	+$1.66K	0.05%	204
2024 Q1	$223K	Buy	+2,473	New	+$210K	0.05%	203
2022 Q4	–	Sell	-2,456	Closed	-$172K	–	293
2022 Q3	$172K	Buy	2,456 +456	+23%	+$35.8K	0.05%	206
2022 Q2	$160K	Hold	2,000	–	–	0.04%	235
2022 Q1	$151K	Hold	2,000	–	–	0.04%	271
2021 Q4	$170K	Hold	2,000	–	–	0.04%	251
2021 Q3	$151K	Sell	2,000 -300	-13%	-$23.8K	0.04%	252
2021 Q2	$187K	Hold	2,300	–	–	0.05%	215
2021 Q1	$181K	Hold	2,300	–	–	0.05%	208
2020 Q4	$197K	Hold	2,300	–	–	0.06%	187
2020 Q3	$177K	Hold	2,300	–	–	0.06%	187
2020 Q2	$167K	Hold	2,300	–	–	0.06%	180
2020 Q1	$150K	Hold	2,300	–	–	0.07%	147
2019 Q4	$156K	Hold	2,300	–	–	0.05%	175
2019 Q3	$164K	Hold	2,300	–	–	0.06%	166
2019 Q2	$165K	Buy	+2,300	New	+$163K	0.06%	167

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Ellis Investment Partners's CL Position: Q1 2025 in Review

Ellis Investment Partners sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 2,496 shares — an estimated $227K sold.

Ellis Investment Partners first reported a position in CL in Q2 2019 and held it in 18 quarters. The position peaked at $259K in Q3 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Ellis Investment Partners reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
Ellis Investment Partners sold 2,496 Colgate-Palmolive shares in Q1 2025, an estimated $227K.
Ellis Investment Partners first reported a position in Colgate-Palmolive in Q2 2019 and held it in 18 quarters.
Ellis Investment Partners's Colgate-Palmolive position peaked at $259K in Q3 2024.
1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Ellis Investment Partners's 13F filing for Q1 2025, filed 22 Apr 2025.